Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-29.97%Return on Assets
VS
Market
Sector
Industry
History
$ 2.75Close
$ 0.73 - $ 3.83 52-Week Range
Ticker Information
Ticker
ESPRCompany Name
ESPERION THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQESPERION THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ESPR - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 347.08M | $ -104.02M | -29.97% |
| 3/31/2025 | $ 324.03M | $ -153.22M | -47.29% |
| 12/31/2024 | $ 343.82M | $ -51.74M | -15.05% |
| 9/30/2024 | $ 314.11M | $ -86.77M | -27.62% |
| 6/30/2024 | $ 352.32M | $ -98.5M | -27.96% |
| 3/31/2024 | $ 373.06M | $ -86.51M | -23.19% |
| 12/31/2023 | $ 205.8M | $ -209.25M | -101.68% |
| 9/30/2023 | $ 221.31M | $ -208.39M | -94.16% |
| 6/30/2023 | $ 234.63M | $ -222.26M | -94.73% |
| 3/31/2023 | $ 251.82M | $ -238.65M | -94.77% |
Key Performance Insights, Last 5 Years
- ESPERION THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -40.25%.
- Over the past 5 years, ESPERION THERAPEUTICS INC's average ROA has been -67.09%.
- The median ROA for ESPERION THERAPEUTICS INC during this period was -69.52%
- ESPERION THERAPEUTICS INC reached its highest ROA over the past 5 years at -15.05%.
- The lowest ROA recorded by ESPERION THERAPEUTICS INC in the same timeframe -136.94%
ESPERION THERAPEUTICS INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for ESPERION THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -101.02M ] / Assets [ $ 250.97M ]
(=) ROA [ -40.25% ] ESPR - Return on Assets, Last 5 years
-136.94%
Minimum
Sep 30, 2021
-15.05%
Maximum
Dec 31, 2024
-67.09%
Average
-69.52%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.1% with a standard deviation of 10.63%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.45K |
|---|---|
| min | -33.42% |
| max | 33.98% |
| average | 0.1% |
| median | 1.53% |
| std | 10.63% |